Pennant Investors »

89bio shares owned by Pennant Investors

Quarter-by-quarter ownership of 89bio (ETNB) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in 89bio

Tip: Access up to 7 years of quarterly data

All positions including 89bio held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 89bio by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $518k 45k 11.64

More positions owned by Pennant Investors

Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Antero Res Call Option (AR)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Echostar Corp Cl A (SATS)
Alphabet Cap Stk Cl A (GOOGL)
Apple Put Option (AAPL)
Colfax Corp (ENOV)
ODP Corp. (ODP)
Perimeter Solutions Sa Common Stock (PRM)
Fibrogen (FGEN)
Arcutis Biotherapeutics (ARQT)
Altimmune Com New (ALT)
Fate Therapeutics (FATE)

View all positions for Pennant Investors

Top funds holding 89bio

RA Capital Management
Henderson Group
Suvretta Capital Management
BVF
BlackRock
Vanguard Group
State Street Corporation
Westfield Capital Management Company
Deep Track Capital
Citadel Advisors
Laurion Capital Management
Geode Capital Management
Redmile Group
MPM Oncology Impact Management
Millennium Management

View all funds holding 89bio